STOCK TITAN

BLND Form 144 reports proposed sale of 4,000 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 4,000 common shares through Charles Schwab & Co., Inc. with an approximate sale date of 10/02/2025 on the NYSE. The shares were acquired on 02/20/2025 as the lapse of restricted stock under the company’s equity compensation plan and were paid by equity compensation.

The filing also lists multiple recent open-market sales by (and an address for) Winnie Ling across July–September 2025, each showing trade dates, share amounts, and gross proceeds. The Form 144 includes the seller’s representation that they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • Proposed sale of 4,000 shares by an insider, scheduled for 10/02/2025
  • Recent multiple open‑market sales by the disclosed seller during July–September 2025 (rows list trade dates, share counts, and proceeds)

Insights

TL;DR: Insider reports a planned sale of 4,000 shares after restricted stock lapse; several recent disposals are also disclosed.

The filing shows the planned disposition of 4,000 common shares to be executed via Charles Schwab around 10/02/2025. The securities were acquired on 02/20/2025 via a restricted stock lapse, and payment is recorded as equity compensation. This is a routine insider liquidation following vesting.

The report enumerates multiple prior sales by the disclosed seller during July–September 2025, each listing shares sold and gross proceeds. Those prior sales provide additional context on the insider’s recent selling activity.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed by Blend Labs (BLND) disclose?

The Form 144 discloses a proposed sale of 4,000 common shares via Charles Schwab, an approximate sale date of 10/02/2025, and that the shares were acquired on 02/20/2025 as a restricted stock lapse under equity compensation.

Who is listed as having sold Blend Labs shares in the past three months?

The filing lists Winnie Ling (address provided) with multiple open-market sales dated between 07/03/2025 and 09/18/2025; each sale row shows the number of shares and gross proceeds.

Through which broker will the proposed BLND sale be executed?

The filing names Charles Schwab & Co., Inc. (3000 Schwab Way, Westlake TX) as the broker for the proposed sale.

How were the shares to be sold originally acquired?

The securities were acquired on 02/20/2025 through a restricted stock lapse from Blend Labs, Inc. and the payment type is recorded as equity compensation.

Does the Form 144 include any statement about material nonpublic information?

Yes. The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Blend Labs Inc

NYSE:BLND

BLND Rankings

BLND Latest News

BLND Latest SEC Filings

BLND Stock Data

789.63M
233.21M
8.79%
65.14%
5.03%
Software - Application
Services-computer Programming, Data Processing, Etc.
Link
United States
NOVATO